Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent.[1]
Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent...
offered to acquire Ablynx for $3.1 billion - having made an unreported offer in mid-December for the company. However, the Ablynx board rejected this...
20 listings, with the exception a one-month period in May–June 2018 when Ablynx stock was removed following the takeover by Sanofi, only to be replaced...
Bioverativ for $11.6 billion and days later announced that it would acquire Ablynx for €3.9 billion ($4.8 billion). In December 2019, the company announced...
thrombocytopenic purpura (TTP) and thrombosis. This drug was developed by Ablynx NV. On 30 August 2018, it was approved in the European Union for the "treatment...
diseases. Ozoralizumab was developed by Pfizer Inc, and now belongs to Ablynx NV. Ablynx has licensed the rights to the antibody in China to Eddingpharm. In...
Global 500". Fortune. "Llama-Based Biotechnology Draws New Interest to Ablynx". Bloomberg. 2015-05-13. Retrieved 2017-12-20. "Alpro - About Alpro". www...
The Ghent University and several research-oriented companies, such as Ablynx, Innogenetics, Cropdesign, and Bayer Cropscience, are situated in the central...
treatment of inflammatory autoimmune diseases. This drug was developed by Ablynx NV to block interleukin-6 receptor. Vobarilizumab has been evaluated in...
of up to 600,000 doses. Other partnerships include collaborations with Ablynx, Gilead Sciences, GlaxoSmithKline, Merck, Novartis, Sanofi and Teva Pharmaceutical...
director of DevGen and CropDesign and is a director of the biotech companies Ablynx, Peakadilly, Actogenix, EMBLEM (technology transfer company of EMBL) and...
rare blood clotting disorders) reached the market in February 2019 (www.ablynx.com). Meanwhile, IP limitations on VHHs are diminishing and more biotechnology...
in the creation of spin-offs from academic research groups, such as for Ablynx, DevGen, CropDesign, ActoGeniX, Pronota (formerly Peakadilly), Agrosavfe...
Biotechnologie (VIB). He was involved in the foundation of three spin-off companies: Ablynx, Biotalys, and Confo Therapeutics. Steyaert was born in Ukkel, Belgium....
single-domain antibodies or nanobodies. Flanders Institute for Biotechnology (VIB) Ablynx "(Dutch) Prof. Em. Raymond Hamers, ontdekker nanobodies, overleden". Medi-Sfeer...
Global Information